• Je něco špatně v tomto záznamu ?

Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients

R. Prikryl, L. Ustohal, HP. Kucerova, T. Kasparek, J. Jarkovsky, V. Hublova, M. Vrzalova, E. Ceskova,

. 2014 ; 49 (-) : 30-5.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, randomizované kontrolované studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014580

INTRODUCTION: High-frequency repetitive transcranial magnetic stimulation (rTMS) over the left dorsolateral prefrontal cortex (DLPFC) seemed to decrease tobacco consumption and craving in nicotine-dependent people without psychiatric disorder or otherwise healthy people. Even if the prevalence of cigarette smoking in schizophrenia patients is high and estimated to be between 45% and 88%, this technique has not been systematically studied in this indication in schizophrenia yet. THE AIM OF THE STUDY: The aim of this study was to test the ability of high-frequency (10Hz) rTMS over the left DLPFC to decrease cigarette consumption in schizophrenia patients. METHODS: The study included 35 male schizophrenia patients on stable antipsychotic medication. The patients were divided into two groups: the first (18 patients) were actively stimulated and the second (17 patients) underwent sham (placebo) stimulation. The sham rTMS was administered using a purpose-built sham coil that was identical in appearance to the real coil and made the same noise but did not deliver a substantial stimulus. The rTMS was administered at the stimulation parameters: location (left dorsolateral prefrontal cortex: DLPFC), intensity of magnetic stimulation in % of motor threshold (110%), stimulation frequency (10Hz), number of trains (20), single train duration (10s), inter-train interval (30s), and total number of stimulation sessions (21). In each stimulation session, 2000TMSpulses were given, with a total of 42,000pulses per treatment course. Patients noted the number of cigarettes smoked in the 7days before treatment, during the whole stimulation treatment (21days), and again for a 7-day period after treatment. RESULTS: Cigarette consumption was statistically significantly lower in the actively stimulated patients than in the sham rTMS group as early as the first week of stimulation. No statistically relevant correlations were found in the changes of ongoing negative or depressive schizophrenia symptoms and the number of cigarettes smoked. CONCLUSION: High-frequency rTMS over the left DLPFC has the ability to decrease the number of cigarettes smoked in schizophrenia patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014580
003      
CZ-PrNML
005      
20170213141849.0
007      
ta
008      
150420s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.pnpbp.2013.10.019 $2 doi
035    __
$a (PubMed)24211840
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Prikryl, Radovan $u CEITEC - Central European Institute of Technology, Masaryk University, Czech Republic; Department of Psychiatry Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Psychiatry, University Hospital Brno, Czech Republic. Electronic address: radovan.prikryl@post.cz.
245    10
$a Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients / $c R. Prikryl, L. Ustohal, HP. Kucerova, T. Kasparek, J. Jarkovsky, V. Hublova, M. Vrzalova, E. Ceskova,
520    9_
$a INTRODUCTION: High-frequency repetitive transcranial magnetic stimulation (rTMS) over the left dorsolateral prefrontal cortex (DLPFC) seemed to decrease tobacco consumption and craving in nicotine-dependent people without psychiatric disorder or otherwise healthy people. Even if the prevalence of cigarette smoking in schizophrenia patients is high and estimated to be between 45% and 88%, this technique has not been systematically studied in this indication in schizophrenia yet. THE AIM OF THE STUDY: The aim of this study was to test the ability of high-frequency (10Hz) rTMS over the left DLPFC to decrease cigarette consumption in schizophrenia patients. METHODS: The study included 35 male schizophrenia patients on stable antipsychotic medication. The patients were divided into two groups: the first (18 patients) were actively stimulated and the second (17 patients) underwent sham (placebo) stimulation. The sham rTMS was administered using a purpose-built sham coil that was identical in appearance to the real coil and made the same noise but did not deliver a substantial stimulus. The rTMS was administered at the stimulation parameters: location (left dorsolateral prefrontal cortex: DLPFC), intensity of magnetic stimulation in % of motor threshold (110%), stimulation frequency (10Hz), number of trains (20), single train duration (10s), inter-train interval (30s), and total number of stimulation sessions (21). In each stimulation session, 2000TMSpulses were given, with a total of 42,000pulses per treatment course. Patients noted the number of cigarettes smoked in the 7days before treatment, during the whole stimulation treatment (21days), and again for a 7-day period after treatment. RESULTS: Cigarette consumption was statistically significantly lower in the actively stimulated patients than in the sham rTMS group as early as the first week of stimulation. No statistically relevant correlations were found in the changes of ongoing negative or depressive schizophrenia symptoms and the number of cigarettes smoked. CONCLUSION: High-frequency rTMS over the left DLPFC has the ability to decrease the number of cigarettes smoked in schizophrenia patients.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prefrontální mozková kůra $x fyziologie $7 D017397
650    12
$a schizofrenie (psychologie) $7 D012565
650    _2
$a kouření $x psychologie $x terapie $7 D012907
650    _2
$a odvykání kouření $x metody $7 D016540
650    _2
$a určení symptomu $7 D063189
650    12
$a transkraniální magnetická stimulace $7 D050781
650    _2
$a mladý dospělý $7 D055815
650    _2
$a prevence kouření $7 D000074606
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ustohal, Libor $u CEITEC - Central European Institute of Technology, Masaryk University, Czech Republic; Department of Psychiatry Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Psychiatry, University Hospital Brno, Czech Republic.
700    1_
$a Kucerova, Hana Prikrylova $u CEITEC - Central European Institute of Technology, Masaryk University, Czech Republic; Department of Psychiatry Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Psychiatry, University Hospital Brno, Czech Republic.
700    1_
$a Kasparek, Tomas $u CEITEC - Central European Institute of Technology, Masaryk University, Czech Republic; Department of Psychiatry Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Psychiatry, University Hospital Brno, Czech Republic.
700    1_
$a Jarkovsky, Jiri $u Institute for Biostatistics and Analyses of the Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Hublová, Veronika $u CEITEC - Central European Institute of Technology, Masaryk University, Czech Republic; Department of Psychiatry Faculty of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0161774
700    1_
$a Vrzalova, Michaela $u CEITEC - Central European Institute of Technology, Masaryk University, Czech Republic; Department of Psychiatry Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Psychiatry, University Hospital Brno, Czech Republic.
700    1_
$a Ceskova, Eva $u CEITEC - Central European Institute of Technology, Masaryk University, Czech Republic; Department of Psychiatry Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Psychiatry, University Hospital Brno, Czech Republic.
773    0_
$w MED00003930 $t Progress in neuro-psychopharmacology & biological psychiatry $x 1878-4216 $g Roč. 49, č. - (2014), s. 30-5
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24211840 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20170213142031 $b ABA008
999    __
$a ok $b bmc $g 1072161 $s 897458
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 49 $c - $d 30-5 $i 1878-4216 $m Progress in neuro-psychopharmacology & biological psychiatry $n Prog Neuropsychopharmacol Biol Psychiatry $x MED00003930
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...